Pathologic Role of Peptidyl-prolyl Isomerase Pin1 in Pulmonary Artery Remodeling

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2021 Nov 17

PMID 34786049

Authors

Caixia Wu

Yanping Ha

Yuan Zou

Xiaomin Liao

Shuya Zhang

Xiaodian Zhang

Rujia Li

Jingci Xing

Wei Jie

Junli Guo

Jingquan Li

Zhihua Shen

Affiliations

Soon will be listed here.

Abstract

Peptidyl-prolyl isomerase Pin1 is crucial for cell proliferation, but its role in pulmonary artery remodeling (PAR) is unclear. In the present study, we aimed to evaluate the expression and contribution of Pin1 in PAR. Treatment with Pin1 inhibitor Juglone or Pin1-specific siRNAs ameliorated the expression of Pin1 and proliferating cell nuclear antigen (PCNA) in human pulmonary artery smooth muscle cells (PASMCs) , and Juglone treatment arrested the cell cycle at the G1 phase. Treatment with transforming growth factor β1 (TGF-β1) also enhanced Pin1 expression and PASMC proliferation. Immunohistochemical staining revealed that Pin1 and PCNA expression levels were increased and positively correlated with each other in PAR samples from humans and monocrotaline-treated Sprague-Dawley rats; these proteins were mainly localized in arteries undergoing remodeling, as well as inflammatory cells, and hyperplastic bronchial epithelial cells. Intraperitoneal injection of Juglone also led to morphologic and hemodynamic changes in PAR rats. Additionally, PAR rats displayed higher serum and lung TGF-β1 levels compared with controls, while administration of Juglone to PAR rats suppressed serum and lung TGF-β1 levels. The findings in this study suggest that TGF-β1 and Pin1 constitute a positive feedback loop, which plays an important role in the pathophysiology of PAR.

References

Chao S, Greenleaf A, Price D . Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res. 2001; 29(3):767-73. PMC: 30403. DOI: 10.1093/nar/29.3.767. View

Liang E, Cheng W, Yang R, Bai W, Liu X, Zhao Y . Peptidyl-prolyl isomerase Pin1 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation in ApoE mice. J Mol Cell Cardiol. 2017; 114:334-344. DOI: 10.1016/j.yjmcc.2017.12.006. View

Aithal K, Kumar S, Nageshwar Rao B, Udupa N, Rao S . Tumor growth inhibitory effect of juglone and its radiation sensitizing potential: in vivo and in vitro studies. Integr Cancer Ther. 2011; 11(1):68-80. DOI: 10.1177/1534735411403477. View

Sheares K, Jeffery T, Long L, Yang X, Morrell N . Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2004; 287(5):L919-27. DOI: 10.1152/ajplung.00012.2004. View

Esnault S, Shen Z, Whitesel E, Malter J . The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. J Immunol. 2006; 177(10):6999-7006. DOI: 10.4049/jimmunol.177.10.6999. View

Tajsic T, Morrell N . Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension. Compr Physiol. 2013; 1(1):295-317. DOI: 10.1002/cphy.c100026. View

McLaughlin V, Shah S, Souza R, Humbert M . Management of pulmonary arterial hypertension. J Am Coll Cardiol. 2015; 65(18):1976-97. DOI: 10.1016/j.jacc.2015.03.540. View

Pu X, Du L, Hu Y, Fan Y, Xu Q . Stem/Progenitor Cells and Pulmonary Arterial Hypertension. Arterioscler Thromb Vasc Biol. 2020; 41(1):167-178. DOI: 10.1161/ATVBAHA.120.315052. View

Qin Y, Yan G, Qiao Y, Wang D, Luo E, Hou J . Emerging role of long non-coding RNAs in pulmonary hypertension and their molecular mechanisms (Review). Exp Ther Med. 2020; 20(6):164. PMC: 7571311. DOI: 10.3892/etm.2020.9293. View

10.

Bueno-Beti C, Sassi Y, Hajjar R, Hadri L . Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration. Methods Mol Biol. 2018; 1816:233-241. DOI: 10.1007/978-1-4939-8597-5_18. View

11.

Ranchoux B, Harvey L, Ayon R, Babicheva A, Bonnet S, Chan S . Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series). Pulm Circ. 2017; 8(1):2045893217752912. PMC: 5798691. DOI: 10.1177/2045893217752912. View

12.

Hoeper M, Bogaard H, Condliffe R, Frantz R, Khanna D, Kurzyna M . Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 Suppl):D42-50. DOI: 10.1016/j.jacc.2013.10.032. View

13.

Thacker P, Karunagaran D . Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells. PLoS One. 2015; 10(3):e0120045. PMC: 4365016. DOI: 10.1371/journal.pone.0120045. View

14.

Lu K, Hanes S, Hunter T . A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature. 1996; 380(6574):544-7. DOI: 10.1038/380544a0. View

15.

Liu N, Parry S, Xiao Y, Zhou S, Liu Q . Molecular targets of the Warburg effect and inflammatory cytokines in the pathogenesis of pulmonary artery hypertension. Clin Chim Acta. 2017; 466:98-104. DOI: 10.1016/j.cca.2017.01.015. View

16.

Long L, Crosby A, Yang X, Southwood M, Upton P, Kim D . Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation. 2009; 119(4):566-76. DOI: 10.1161/CIRCULATIONAHA.108.821504. View

17.

Jie W, Wang X, Huang L, Guo J, Kuang D, Zhu P . Contribution of CXCR4(+)/PDGFRbeta(+) progenitor cells in hypoxic alveolar arterioles muscularization: role of myocardin. Cardiovasc Res. 2010; 87(4):740-50. DOI: 10.1093/cvr/cvq147. View

18.

Chen J, An R, Liu Z, Wang J, Chen S, Hong M . Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats. Acta Pharmacol Sin. 2014; 35(9):1121-8. PMC: 4155533. DOI: 10.1038/aps.2014.61. View

19.

Wu D, Huang D, Li L, Ni P, Li X, Wang B . TGF-β1-PML SUMOylation-peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) form a positive feedback loop to regulate cardiac fibrosis. J Cell Physiol. 2018; 234(5):6263-6273. DOI: 10.1002/jcp.27357. View

20.

Wang R, Jiang F, Zheng Q, Li C, Peng X, He C . Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review. Respir Med. 2014; 108(3):531-7. DOI: 10.1016/j.rmed.2014.01.003. View